Dark

OGN
Organon & Co.
stock NYSE

At Close

Sep 22, 2026 3:59:58 PM EDT

13.71USD+0.219%(+0.03)1,364,976

13.69Bid 13.73Ask 0.04Spread

Pre-market

0.00USD-100.000%(-13.68)0

After-hours

Sep 22, 2026 4:18:47 PM EDT

13.71USD0.000%(0.00)7

OverviewOptionsHistoricalExchangesShortsNews

Jan 11, 2022

07:00AM EST NEXPLANON(r) (ETONOGESTREL EXTENDED-RELEASE SUBDERMAL IMPLANT) NOW COVERED BY PR Newswire

Jan 5, 2022

06:31AM EST FDA Accepts Samsung Bioepis' And Organon's sBLA For Their Citrate-Free, High-Concentration HUMIRA Biosimilar Candidate Benzinga

Nov 23, 2021

07:17AM EST Novartis May Have Buyer(s) For Its Sandoz Unit - Report Benzinga

Nov 19, 2021

11:37AM EST Organon Shares Volatile, Make Parabolic Move Higher Then Sell Off; FDA AccessData.gov Listing For Co.'s Mirtazapine Shows FDA Approved Benzinga

Nov 18, 2021

07:55AM EST Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3 Benzinga

Nov 17, 2021

02:00PM EST Accenture, Organon Team Up To Drive Digital Transformation For Better Patient And Employee Experiences Benzinga

Nov 11, 2021

02:01PM EST Lower Sales Impact Organon's Q3 Margins; Acquires Forendo Pharma For Over $900M Benzinga

06:39AM EST Organon Q3 EPS $1.67 Beats $1.44 Estimate, Sales $1.60B Beat $1.58B Estimate Benzinga

06:39AM EST Organon To Acquire Forendo Pharma For Total Cash Consideration Of $954M Benzinga

03:55AM EST Earnings Scheduled For November 11, 2021 Benzinga

Nov 8, 2021

02:05PM EST NEXPLANON(r) (etonogestrel extended-release subdermal implant) Now Covered by PR Newswire

Oct 11, 2021

07:34AM EDT Organon Receives FDA Clearance For Technological Updates To The Jada System, A Medical Device Intended To Control Postpartum Hemorrhage Benzinga

Oct 7, 2021

12:18PM EDT Expert Ratings For Organon Benzinga

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021 Benzinga

05:17AM EDT Piper Sandler Initiates Coverage On Organon with Neutral Rating, Announces Price Target of $35 Benzinga

Sep 22, 2021

06:00AM EDT Organon wants to help women take control of their birth control PR Newswire

Sep 1, 2021

12:45PM EDT What 6 Analyst Ratings Have To Say About Organon Benzinga

11:04AM EDT 3 Reasons To Buy Organon Stock, Says BofA Analyst Benzinga

10:13AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021 Benzinga

08:57AM EDT B of A Securities Initiates Coverage On Organon with Buy Rating, Announces Price Target of $43 Benzinga

Aug 16, 2021

04:34PM EDT 13F From Warren Buffett's Berkshire Hathaway Shows New Stake In Organon, Raised Stake In Kroger, Liquidated Stakes In Axalta Coating Systems, Biogen Benzinga

09:01AM EDT Morgan Stanley Maintains Equal-Weight on Organon, Raises Price Target to $35 Benzinga

Aug 12, 2021

12:08PM EDT New Jersey-based healthcare company Organon & Co. (OGN) is 10% higher on the market after announcing a dividend for the stakeholders on Thursday. RTTNews

08:09AM EDT The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma Benzinga

07:27AM EDT Organon Q2 EPS $1.72 Beats $1.42 Estimate, Sales $1.59B Beat $1.52B Estimate Benzinga

04:14AM EDT Earnings Scheduled For August 12, 2021 Benzinga

Aug 9, 2021

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Jul 27, 2021

11:13AM EDT The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts Benzinga

06:26AM EDT ObsEva Stock Surges On Potential $500M Ebopiprant Deal For Preterm Labor Benzinga

Jul 23, 2021

10:24AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021 Benzinga

08:48AM EDT Citigroup Initiates Coverage On Organon with Buy Rating, Announces Price Target of $35 Benzinga

Jul 22, 2021

10:11AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 22, 2021 Benzinga

09:00AM EDT Citigroup Initiates Coverage On Organon with Buy Rating, Announces Price Target of $35 Benzinga

Jul 15, 2021

08:24AM EDT Why Ocugen Shares Are Rallying Today Benzinga

Jun 25, 2021

12:47PM EDT UPDATE: Evercore Says Understands Microspherix Has Granted Organon, Merck A Covenant Not To Sue Under U.S. Patent No. 10,994,058. Benzinga

12:46PM EDT Evercore Says Picking Up Positive Development On Legal Front At Organon, Says Organon, Merck Have Voluntarily Dismissed New Case Against Microspherix Benzinga

07:01AM EDT OTC Markets Group Welcomes Orogen Royalties Inc. to OTCQX PR Newswire

Jun 15, 2021

10:24AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 Benzinga

09:20AM EDT JP Morgan Initiates Coverage On Organon with Neutral Rating, Announces Price Target of $38 Benzinga

Jun 11, 2021

11:32AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021 Benzinga

07:34AM EDT Morgan Stanley Initiates Coverage On Organon with Equal-Weight Rating, Announces Price Target of $33 Benzinga

Jun 10, 2021

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2021 Benzinga

09:16AM EDT Evercore ISI Group Initiates Coverage On Organon with Outperform Rating Benzinga

Jun 8, 2021

12:10PM EDT Shares of pharmaceutical company Organon & Co. (OGN) are down 5 percent on Tuesday's trading despite there being no company announcement or other news to impact the stock. RTTNews

Jun 3, 2021

12:42PM EDT Merck Completes Women's Health Organon Spinoff Benzinga

06:00AM EDT Organon Canada Launches as New Women's Health Company PR Newswire

May 27, 2021

05:48PM EDT Organon Set to Join S&P 500; HollyFrontier to Join S&P MidCap 400; Service PR Newswire

.dark-mode .n0JvmQ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .n0JvmQ{ color: #333333; background-color: white; border: 2px solid #333333; }OGNOrganon & Co.stock NYSE

OGN
Organon & Co.
stock NYSE